Laura Barbagallo

Laura Barbagallo serves as a Contract Professor in the Department of Experimental Medicine (DIMES) at the University of Genoa, Italy, and concurrently holds a position at IRCCS Giannina Gaslini Institute's Department of Translational Research, Laboratory Medicine, Diagnostics and Services within the UOC Analysis Laboratory (Via Gerolamo Gaslini 5, 16147 Genoa). Her professional contact includes laura.barbagallo@edu.unige.it and LauraBarbagallo@gaslini.org, with appointments available via email.

Her research specializes in therapeutic drug monitoring using chromatographic techniques, with dual focus on cystic fibrosis treatments (particularly CFTR modulators: ivacaftor, tezacaftor, elexacaftor) and antibacterial drug harmonization. This work bridges clinical pharmacology and diagnostic laboratory science, emphasizing precise drug level measurement to optimize dosing regimens and improve patient outcomes in chronic respiratory and infectious diseases.

Recent publications demonstrate her expertise in applying chromatography to therapeutic monitoring challenges: the 2023 cystic fibrosis study addresses triple-combination modulator monitoring, while the 2022 antibacterial research establishes standardized therapeutic intervals. These contributions fall within pharmacology and clinical medicine, specifically advancing personalized drug therapy through laboratory innovation.

At IRCCS Giannina Gaslini Institute, she contributes to the UOC Analysis Laboratory's mission of providing translational research and diagnostic services that directly support clinical decision-making and patient care in pediatric and adult specialties.